SK Biopharmaceuticals Co Ltd
KRX:326030
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
75 700
125 900
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
SK Biopharmaceuticals Co Ltd
SK Biopharmaceuticals Co Ltd
Total Current Liabilities
SK Biopharmaceuticals Co Ltd
Total Current Liabilities Peer Comparison
000100
008930
128940
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Total Current Liabilities
₩241.6B
|
CAGR 3-Years
51%
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
|
|
Yuhan Corp
KRX:000100
|
Total Current Liabilities
₩648.6B
|
CAGR 3-Years
19%
|
CAGR 5-Years
19%
|
CAGR 10-Years
12%
|
|
|
Hanmi Science Co Ltd
KRX:008930
|
Total Current Liabilities
₩401.4B
|
CAGR 3-Years
23%
|
CAGR 5-Years
13%
|
CAGR 10-Years
4%
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Total Current Liabilities
₩678.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
8%
|
CAGR 10-Years
15%
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Total Current Liabilities
₩74.2B
|
CAGR 3-Years
32%
|
CAGR 5-Years
14%
|
CAGR 10-Years
12%
|
|
C
|
Celltrion Pharm Inc
KOSDAQ:068760
|
Total Current Liabilities
₩248.3B
|
CAGR 3-Years
9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
16%
|
See Also
What is SK Biopharmaceuticals Co Ltd's Total Current Liabilities?
Total Current Liabilities
241.6B
KRW
Based on the financial report for Dec 31, 2023, SK Biopharmaceuticals Co Ltd's Total Current Liabilities amounts to 241.6B KRW.
What is SK Biopharmaceuticals Co Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
51%
Over the last year, the Total Current Liabilities growth was 48%. The average annual Total Current Liabilities growth rates for SK Biopharmaceuticals Co Ltd have been 51% over the past three years , 51% over the past five years .
You don't have any saved screeners yet
